Sun GY,Chuang DY,Zong Y,et al.Role of cytosolic phospholipase A2in oxidative and inflammatory signaling pathways in different cell types in the central nervous system[J].Mol Neurobiol,2014,50(1):6-14.
[2]
Murakami M,Taketomi Y,Miki Y,et al.Recent progress in phospholipase A(2)research:from cells to animals to humans[J].Prog Lipid Res,2011,50(2):152-192.
[3]
Calder PC.The relationship between the fatty acid composition of immune cells and their function[J].Prostaglandins Leukot Essent Fatty Acids,2008,79(3-5):101-108.
[4]
Sun GY,Chuang DY,Zong Y,et al.Role of cytosolic phospholipase A2in oxidative and inflammatory signaling pathways in different cell types in the central nervous system[J].Mol Neurobiol,2014,50(1):6-14.
[5]
Drakaki A,Hatziapostolou M,Polytarchou C,et al.Functional microRNA high throughput screening reveals miR-9as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway[J].BMC Cancer,2015,15:542.
[6]
Galkina E,Ley K.Immune and inflammatory mechanisms of atherosclerosis[J].Annu Rev Immunol,2009,27:165-197.
[7]
Ohata T,Yokoo H,Kamiyama T,et al.Fatty acidbinding protein 5function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition[J].Cancer Med,2017,6(5):1 049-1 061.
[8]
Song J,Ping LY,Duong DM,et al.Native low density lipoprotein promotes lipid raft formation in macrophages[J].Mol Med Rep,2016,13(3):2 087-2 093.
Lee WS,Kim J.Peroxisome proliferator-activated receptors and the heart:lessons from the past and future directions[J].PPAR Res,2015,2015:271983.
[11]
Long H,Wang L,Su H,et al.Increased circulatory RAS activity can be inhibited by statins in patients with hypercholesterolemia[J].J Renin Angiotensin Aldosterone Syst,2015,16(1):126-130.
